Status:
RECRUITING
Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.
Lead Sponsor:
ART Fertility Clinics LLC
Conditions:
Infertility
Fertility Issues
Eligibility:
FEMALE
18-43 years
Phase:
PHASE1
Brief Summary
The goal of this study is to compare the difference in clinical pregnancy, miscarriage and livebirth rate between day 6 euploid blastocyst transfer on the 6th and the 7th day of progesterone exposure ...
Detailed Description
Traditionally the duration of progesterone exposure before embryo transfer has been considered equal for day 5 and day 6 embryos but this may not be the case and warrants further study. The optimal pr...
Eligibility Criteria
Inclusion
- Women aged 18 years to 43 years.
- Having at least 1 euploid cryopreserved day 6 blastocyst of at least Grade BB quality.
- Endometrial trilaminar appearance on the day of progesterone start
Exclusion
- Uterine abnormality
- Hydrosalpinx
- Asherman syndrome
- Any known contraindications or allergy to oral estradiol or progesterone.
- Intention to treat : exclusion factors :
- Spontaneous ovulation HRT cycle
- Discontinuation of HRT medication
Key Trial Info
Start Date :
September 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
316 Patients enrolled
Trial Details
Trial ID
NCT05980091
Start Date
September 22 2023
End Date
December 30 2025
Last Update
February 21 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
ART Fertility Clinics LLC
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates, 60202
2
ART Fertility Clinics Dubai
Dubai, United Arab Emirates